Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Annika
Annika Algars, Kuusisto FI
| Patent application number | Description | Published |
|---|---|---|
| 20110217296 | METHOD FOR SELECTING PATIENTS FOR TREATMENT WITH AN EGFR INHIBITOR - The present invention relates to cancer diagnostics and therapies and to the detection of alterations in cancer cells that are diagnostic, prognostic or predictive. In particular, the present invention provides a method for detecting and analyzing whether a patient suffering from a cancer is responsive to the treatment with an EGFR inhibitor. In the method, a tissue section from a cancer sample is subjected to assays based on immunohistochemistry and enzymatic metallography. | 09-08-2011 |
Annika Birkler, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20090034232 | FUEL DISPENSING UNIT HOUSING - A housing for a fuel dispensing unit comprises a top part, a bottom part and at least one column extending between the bottom part and the top part. Said bottom part comprises a light emitting device arranged to emit light, and said top part comprises a light directing device for directing the emitted light towards the bottom part. | 02-05-2009 |
Annika Bjore, Stenungsund SE
| Patent application number | Description | Published |
|---|---|---|
| 20090326221 | New oxabispidine compunds useful in the treatment of cardiac arrhythmias - There is provided compounds of formula I, | 12-31-2009 |
Annika Brobach, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20090259990 | Mobile Device Software Management Method and Apparatus - Mobile device software is managed by providing an interface between a plurality of software module handlers and a plurality of software modules. The interface is invoked responsive to a software module event such as the installation, removal, activation or modification of a software module. The interface identifies the software module and a corresponding attribute list associated with the software module event. The attribute list specifies one or more actions to be taken by at least one of the software module handlers that enable the identified software module to provide one or more functions when invoked. The attribute list is provided to each software module handler identified in the list and each action specified in the list is taken by the corresponding software module handler. This way, the interface reliably manages the different software modules without being aware of the particular functions provided by the modules or the specific actions taken by the handlers. | 10-15-2009 |
Annika Halwe-Bommelmann, Rahden DE
| Patent application number | Description | Published |
|---|---|---|
| 20110175346 | RIGID FOAM ENVELOPMENT OF THE CONNECTIONS OF PIPES - The invention relates to the envelopment of a connection of at least two pipes or parts thereof by an open-celled rigid foam, the production of such an envelope and also the use of open-celled rigid foam for protecting connections of two pipes. | 07-21-2011 |
Annika Hasselstrom, Vilbdjerg DK
| Patent application number | Description | Published |
|---|---|---|
| 20090272763 | DISPENSER WITH A BAG INSIDE AND METHOD FOR MANUFACTURING OF THE SAME - A dispenser where a container ( | 11-05-2009 |
Annika Hofstetter Olsson, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110008258 | METHODS RELATING TO BREATHING DISORDERS - Methods for treating breathing disorders by inhibition of the induced PGE | 01-13-2011 |
Annika Kotovuori, Vantaa FI
| Patent application number | Description | Published |
|---|---|---|
| 20110143373 | METHOD OF EVALUATING THE INTEGRITY OF THE PLASMA MEMBRANE OF CELLS BY DETECTING GLYCANS FOUND ONLY INTRACELLULARLY - The invention describes novel reagents that can be applied for analysis of the quality of human cells. The method evaluates the integrity of the plasma membrane of the cells by detecting novel glyco structures found only intracellularly. The method can be applied, for example, to demonstrate exposure of therapeutic cell preparation to potentially harmful conditions. It can also be used as a quality control tool in methods in which intact cell membrane is essential and it can be applied in separation of damaged cells from non- damaged. | 06-16-2011 |
Annika Leifert, Aachen DE
| Patent application number | Description | Published |
|---|---|---|
| 20080241258 | TREATMENT OF DISEASES WITH NANOPARTICLES HAVING A SIZE-DEPENDENT CYTOTOXICITY - The present invention relates to the use of at least one gold nanocluster compound in the manufacture of a pharmaceutical composition or medicament for the prophylactic and/or therapeutic (curative) treatment of a disease, especially a tumor and/or cancer disease. The gold nanocluster compound having a defined particle size, especially a defined size of the core of said gold nanocluster compound, the size ranging from 0.5 nm to 10 nm, the outer limits of this range being included. Especially, the gold nanocluster compounds used possess size-dependent cytotoxic properties, stimulating or inducing cellular death when treating and/or contacting respective cells, especially tumor and/or cancer cells, with the gold nanocluster compounds either via apoptosis or via necrosis, depending on the respective gold cluster size or core size. | 10-02-2008 |
| 20110300532 | CONTROL OF THE TOXICITY OF GOLD NANOPARTICLES - The present invention relates to gold nanocluster compounds, especially gold nanoparticles, having a reduced toxicity, especially cytotoxicity, which are preferably appropriate for use in medical diagnostics such as medical imaging (e.g. X-ray, CT etc.), said gold nanocluster compounds comprising a core of at least one gold atom and at least one ligand bound to said core, wherein the reduction of toxicity, especially cytotoxicity, of said gold nanocluster compound is controlled and/or adjusted via its ligand structure and/or its ligand chemistry. | 12-08-2011 |
Annika Mannes, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100260689 | REDUCING SHAVING FREQUENCY - The invention describes the use of acidic aluminum compounds that in cosmetic preparations result in hair softening and a reduction of the shaving frequency. | 10-14-2010 |
Annika Naeslund, Bromma SE
| Patent application number | Description | Published |
|---|---|---|
| 20100016935 | MEDICAL IMPLANTABLE LEAD - A implantable lead an elongate body including a flexible insulating tube, and a tubular conductor layer formed of multiple separate strip conductors, which are arranged at the outer surface of the insulating tube and extend along the length thereof. | 01-21-2010 |
| 20100114279 | MEDICAL IMPLANTABLE LEAD - A medical implantable lead has a proximal end and a distal end, and a flexible flat elongate body. The elongate body includes a layer of strip conductors extending along the length of the flat elongate body, a top insulating layer, and a bottom insulating layer. The layer of strip conductors is sealingly enclosed between the top and bottom insulating layers, and at least a major portion of the flat elongate body is twisted into an elongate helical portion having a central cavity extending longitudinally of the helical portion. | 05-06-2010 |
| 20100168806 | DEVICE AND METHOD FOR TREATING CARDIAC TISSUE OF A HEART OF A PATIENT WITH THERAPEUTIC LIGHT USING PHOTOBIOMODULATION - For treatment of cardiac tissue of a heart of a patient with therapeutic light using an implantable medical device connectable to at least one medical lead carrying electrodes and at least one fixation element that fixes the lead at a fixation area of the cardiac tissue, therapeutic light is emitted toward the at least one fixation area of cardiac tissue and/or toward a contact area between the at least one electrode and cardiac tissue using an intracorporeal light emitter. | 07-01-2010 |
| 20100280563 | DEVICE AND METHOD FOR DETECTING AND TREATING A MYOCARDIAL INFARCTION USING PHOTOBIOMODULATION - In an implantable medical device and a method for treating cardiac tissue of a heart of a patient with therapeutic light, a myocardial infarction is detected and a location the myocardial infarction is identified. A therapy session is initiated by selectively activating one or more of a number of light emitting units arranged in at least one medical lead connectable to the implantable medical device, to emit therapeutic light toward the detected location of the myocardial infarction upon detection of an occurrence of the myocardial infarction. | 11-04-2010 |
| 20110040291 | TISSUE STIMULATING DEVICE AND METHOD - A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells. | 02-17-2011 |
Annika Schmidt, Runkel DE
| Patent application number | Description | Published |
|---|---|---|
| 20110077157 | Oil Suspension Concentrate - The present invention relates to an oil suspension concentrate comprising | 03-31-2011 |
Annika Smedberg, Myggenaes SE
| Patent application number | Description | Published |
|---|---|---|
| 20080308296 | Polyolefin Composition For Use As An Insulating Material - The invention relates to a polymer composition, comprising (a) a polyolefin base resin which comprises at least (a1) a first olefin homo- or copolymer fraction, and (a2) a second olefin homo- or copolymer fraction, wherein the weight average molecular weight of the first fraction is lower than the weight average molecular weight of the second fraction, and (b) at least one additive selected from a polar copolymer; a low density polyethylene; an ether and/or ester group containing additive selected from the group consisting of polyethylene glycol, a glycerol ester compound, polypropylene glycol, an amido group containing fatty acid ester, ethoxylated and/or propoxylated pentaerythritol, an alpha-tocopherol ester, an ethoxylated and/or propoxylated fatty acid, and derivatives thereof; or mixtures of these additives. | 12-18-2008 |
| 20090029166 | POLYMER COMPOSITION HAVING IMPROVED WET AGEING PROPERTIES - The present invention relates to a crosslinkable polymer composition, comprising (i) an unsaturated polyolefin having a total amount of carbon-carbon double bonds/1000 carbon atoms of more than 0.37, and (ii) a polar copolymer | 01-29-2009 |
| 20110061893 | WATER TREE RETARDING COMPOSITION - The present invention relates to a crosslinkable polymer composition, comprising (i) an unsaturated polyolefin having a total amount of carbon-carbon double bonds/1000 carbon atoms of more than 0.37, and (ii) at least one ether and/or ester group containing additive selected from the group consisting of polyethylene glycol, a glycerol ester compound, polypropylene glycol, an amido group containing fatty acid ester, ethoxylated and/or propoxylated pentaerythritol, an alpha-tocopherol ester, an ethoxylated and/or propoxylated fatty acid, and derivatives thereof. | 03-17-2011 |
Annika Sörfeldt, Hisings Karra SE
| Patent application number | Description | Published |
|---|---|---|
| 20110119768 | COMMUNICATION ARRANGEMENT - The present invention relates to a method, node and system for efficient handling of sharing a set of data and in particular where the data set is shared in a volatile manner. Each node with access to the data set sharing group controls the access of data set from the node and each node stores data set received from other nodes in the group in a volatile manner providing removal of data set received from a node that has left the sharing group. | 05-19-2011 |
Annika Stobrawe, Dormagen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120101216 | METHOD FOR PRODUCING POLYMERIC SOLIDS - The invention relates to a method for producing polymeric solids free of auxiliary emulators starting from polymer latices (dispersion), wherein a polymer dispersion with a starting ph-value greater than 9 is set to a ph-value of 6 to 9 by adding gaseous carbon dioxide and the polymer dispersion is subsequently coagulated by shearing and/or freezing. | 04-26-2012 |
Annika Tallsjo, Uppsala SE
| Patent application number | Description | Published |
|---|---|---|
| 20090155801 | METHOD OF SEQUENCING DNA - The present invention provides a method of identifying a base at a target position in a sample nucleic acid sequence, said method comprising: subjecting a primer hybridised to said sample nucleic acid immediately adjacent to the target position, to a polymerase primer extension reaction in the presence of a nucleotide, whereby the nucleotide will only become incorporated if it is complementary to the base in the target position, and determining whether or not said nucleotide is incorporated by detecting whether PPi is released, the identity of the target base being determined from the identity of any nucleotide incorporated, wherein, where said nucleotide comprises an adenine base, an α-thio triphosphate analogue of said nucleotide is used, ant the Rp isomer of said analogue and/or the degradation products of said analogue are eliminated from the polymerase reaction step. | 06-18-2009 |